SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Alcohol-Related Disorders D019973 3 associated lipids
Lead Poisoning D007855 4 associated lipids
Urinary Incontinence D014549 4 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Dyspepsia D004415 5 associated lipids
Hypertension, Renovascular D006978 10 associated lipids
Amnesia D000647 12 associated lipids
Glucose Intolerance D018149 13 associated lipids
Angina, Unstable D000789 14 associated lipids
Brain Infarction D020520 17 associated lipids
Angina Pectoris D000787 27 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Endometriosis D004715 29 associated lipids
Stroke D020521 32 associated lipids
Memory Disorders D008569 33 associated lipids
Burns D002056 34 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Cataract D002386 34 associated lipids
Fever D005334 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Heart Failure D006333 36 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Arthritis D001168 41 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Fatty Liver D005234 48 associated lipids
Parkinson Disease D010300 53 associated lipids
Reperfusion Injury D015427 65 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Coronary Disease D003327 70 associated lipids
Alzheimer Disease D000544 76 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Brain Ischemia D002545 89 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Insulin Resistance D007333 99 associated lipids
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hemolysis D006461 131 associated lipids
Adenocarcinoma D000230 166 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Liao D et al. N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: preparation and evaluation. 2015 Drug Deliv pmid:24467620
Li X et al. Evaluation of Pharmasolve corneal permeability enhancement and its irritation on rabbit eyes. 2009 Drug Deliv pmid:19514982
Zhang L et al. Puerarin transport across a Calu-3 cell monolayer - an in vitro model of nasal mucosa permeability and the influence of paeoniflorin and menthol. 2016 Drug Des Devel Ther pmid:27468226
Zhang L et al. Puerarin transport across rat nasal epithelial cells and the influence of compatibility with peoniflorin and menthol. 2017 Drug Des Devel Ther pmid:28919709
Cui S et al. Self-microemulsifying drug delivery systems (SMEDDS) for improving in vitro dissolution and oral absorption of Pueraria lobata isoflavone. 2005 Drug Dev Ind Pharm pmid:16093200
Li Y et al. Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats. 2006 Drug Dev Ind Pharm pmid:16638679
Xie J et al. Improvement in solubility and bioavailability of puerarin by mechanochemical preparation. 2013 Drug Dev Ind Pharm pmid:22591175
Wu H et al. Enhanced oral bioavailability of puerarin using microemulsion vehicle. 2009 Drug Dev Ind Pharm pmid:19040180
Yao W et al. Preparation and characterization of puerarin-dendrimer complexes as an ocular drug delivery system. 2010 Drug Dev Ind Pharm pmid:20545508
Wu JY et al. A microemulsion of puerarin-phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations. 2018 Drug Dev Ind Pharm pmid:29513046
Tang X et al. Phytoestrogens induce differential estrogen receptor beta-mediated responses in transfected MG-63 cells. 2008 Aug-Dec Endocrine pmid:18937077
Braune A and Blaut M Deglycosylation of puerarin and other aromatic C-glucosides by a newly isolated human intestinal bacterium. 2011 Environ. Microbiol. pmid:20946528
Yang S et al. Protective effects of puerarin against tetrabromobisphenol a-induced apoptosis and cardiac developmental toxicity in zebrafish embryo-larvae. 2015 Environ. Toxicol. pmid:24596333
Liu CM et al. Protective effect of puerarin on lead-induced mouse cognitive impairment via altering activities of acetyl cholinesterase, monoamine oxidase and nitric oxide synthase. 2013 Environ. Toxicol. Pharmacol. pmid:23501611
Cheng HH et al. Effects of puerarin on intracellular Ca and cell viability of MDCK renal tubular cells. 2017 Environ. Toxicol. Pharmacol. pmid:28384516
Wang S et al. Efficient glycosylation of puerarin by an organic solvent-tolerant strain of Lysinibacillus fusiformis. 2014 Enzyme Microb. Technol. pmid:24629266
Li P et al. In Vivo Pharmacokinetics of Puerarin via Different Drug Administration Routes Based on Middle Cerebral Artery Occlusion Model. 2017 Eur J Drug Metab Pharmacokinet pmid:27928655
Wu H et al. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems. 2011 Eur J Pharm Sci pmid:21216284
Xiong FL et al. Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. 2006 Eur. J. Pharmacol. pmid:16321378
Xiao C et al. Anti-oxidative and TNF-α suppressive activities of puerarin derivative (4AC) in RAW264.7 cells and collagen-induced arthritic rats. 2011 Eur. J. Pharmacol. pmid:21651907
Yeung DK et al. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. 2006 Eur. J. Pharmacol. pmid:17027964
Li J et al. Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo. 2010 Eur. J. Pharmacol. pmid:20868658
Zhang W et al. Puerarin improves insulin resistance and modulates adipokine expression in rats fed a high-fat diet. 2010 Eur. J. Pharmacol. pmid:20869961
Lu XL et al. Protective effects of puerarin against Aß40-induced vascular dysfunction in zebrafish and human endothelial cells. 2014 Eur. J. Pharmacol. pmid:24690262
Li CH et al. Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages. 2017 Eur. J. Pharmacol. pmid:28576406
Chen X et al. Puerarin acts on the skeletal muscle to improve insulin sensitivity in diabetic rats involving μ-opioid receptor. 2018 Eur. J. Pharmacol. pmid:29061371
Lin F et al. Puerarin facilitates Ca(2+)-induced Ca(2+) release triggered by KCl-depolarization in primary cultured rat hippocampal neurons. 2007 Eur. J. Pharmacol. pmid:17610871
Chung MJ et al. Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in HepG2 cells and in C57 BL/6J mice. 2008 Eur. J. Pharmacol. pmid:17976573
Gao Q et al. Opening the calcium-activated potassium channel participates in the cardioprotective effect of puerarin. 2007 Eur. J. Pharmacol. pmid:17692311
Liu IM and Cheng JT Mediation of Endogenous β-Endorphin in the Plasma Glucose-Lowering Action of Herbal Products Observed in Type 1-Like Diabetic Rats. 2011 Evid Based Complement Alternat Med pmid:19095661
Fan R et al. Ethnopharmacokinetic- and activity-guided isolation of a new antidepressive compound from fructus aurantii found in the traditional chinese medicine chaihu-shugan-san: a new approach and its application. 2012 Evid Based Complement Alternat Med pmid:22454671
Luo J and Xu H Outcome measures of chinese herbal medicine for coronary heart disease: an overview of systematic reviews. 2012 Evid Based Complement Alternat Med pmid:22606207
Wang J and Xiong X Current situation and perspectives of clinical study in integrative medicine in china. 2012 Evid Based Complement Alternat Med pmid:22550539
Jiang H et al. Natural product nitric oxide chemistry: new activity of old medicines. 2012 Evid Based Complement Alternat Med pmid:22548122
Qiu Y et al. Traditional chinese herbal products for coronary heart disease: an overview of cochrane reviews. 2012 Evid Based Complement Alternat Med pmid:22536282
Zheng GH et al. Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention. 2012 Evid Based Complement Alternat Med pmid:22454659
Pan SY et al. New perspectives on chinese herbal medicine (zhong-yao) research and development. 2011 Evid Based Complement Alternat Med pmid:21785622
Kim J et al. KIOM-79 Prevents Lens Epithelial Cell Apoptosis and Lens Opacification in Zucker Diabetic Fatty Rats. 2011 Evid Based Complement Alternat Med pmid:20953387
Mun JG et al. Tracking deposition of a 14C-radiolabeled kudzu hairy root-derived isoflavone-rich fraction into bone. 2010 Exp. Biol. Med. (Maywood) pmid:20851832
Wang K et al. Puerarin inhibits amyloid β-induced NLRP3 inflammasome activation in retinal pigment epithelial cells via suppressing ROS-dependent oxidative and endoplasmic reticulum stresses. 2017 Exp. Cell Res. pmid:28583762
Zhang H et al. Puerarin protects Alzheimer's disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways. 2011 Exp. Gerontol. pmid:20933077
Thielemann A et al. Comparison of urodynamic effects of phytoestrogens equol, puerarin and genistein with these of estradiol 17beta in ovariectomized rats. 2010 Exp. Gerontol. pmid:19903517
Liu CM et al. Puerarin protects the rat liver against oxidative stress-mediated DNA damage and apoptosis induced by lead. 2012 Exp. Toxicol. Pathol. pmid:21146379
Keung WM and Vallee BL Therapeutic lessons from traditional Oriental medicine to contemporary Occidental pharmacology. 1994 EXS pmid:8032168
Pan ZY et al. The myocardial protective effects of puerarin on STZ-induced diabetic rats. 2009 Fen Zi Xi Bao Sheng Wu Xue Bao pmid:19537197
Cao L et al. Pharmacokinetics of puerarin in pregnant rats at different stages of gestation after oral administration. 2013 Fitoterapia pmid:23500385
Malaivijitnond S et al. Puerarin exhibits weak estrogenic activity in female rats. 2010 Fitoterapia pmid:20117180
Liu G et al. Hydroxylation modification and free radical scavenging activity of puerarin-7-O-fructoside. 2011 Folia Microbiol. (Praha) pmid:21818614
Clarke DB et al. Determination of phytoestrogens in dietary supplements by LC-MS/MS. 2008 Food Addit Contam Part A Chem Anal Control Expo Risk Assess pmid:18478479
Fan JP et al. Optimization of ionic liquid based ultrasonic assisted extraction of puerarin from Radix Puerariae Lobatae by response surface methodology. 2012 Food Chem pmid:22980805
Wang S et al. Optimization of ionic liquids-based microwave-assisted hydrolysis of puerarin and daidzein derivatives from Radix Puerariae Lobatae extract. 2018 Food Chem pmid:29606431
Ma JQ et al. Puerarin ameliorates carbon tetrachloride-induced oxidative DNA damage and inflammation in mouse kidney through ERK/Nrf2/ARE pathway. 2014 Food Chem. Toxicol. pmid:24975872
Yu C et al. Decreased expression of aromatase in the Ishikawa and RL95-2 cells by the isoflavone, puerarin, is associated with inhibition of c-jun expression and AP-1 activity. 2008 Food Chem. Toxicol. pmid:18848966
Liu CM et al. Protective role of puerarin on lead-induced alterations of the hepatic glutathione antioxidant system and hyperlipidemia in rats. 2011 Food Chem. Toxicol. pmid:22001170
Guo C et al. Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway. 2013 Food Chem. Toxicol. pmid:23500774
Li R et al. Puerarin mediates hepatoprotection against CCl4-induced hepatic fibrosis rats through attenuation of inflammation response and amelioration of metabolic function. 2013 Food Chem. Toxicol. pmid:23146695
Xia DZ et al. Hepatoprotective activity of puerarin against carbon tetrachloride-induced injuries in rats: a randomized controlled trial. 2013 Food Chem. Toxicol. pmid:23764356
Wu K et al. Anti-diabetic effects of puerarin, isolated from Pueraria lobata (Willd.), on streptozotocin-diabetogenic mice through promoting insulin expression and ameliorating metabolic function. 2013 Food Chem. Toxicol. pmid:23927877
She S et al. Effects of puerarin in STZ-induced diabetic rats by oxidative stress and the TGF-β1/Smad2 pathway. 2014 Food Funct pmid:24595557
Tu YM et al. A high concentration of fatty acids induces TNF-α as well as NO release mediated by the P2X4 receptor, and the protective effects of puerarin in RAW264.7 cells. 2017 Food Funct pmid:28937704
Barnes S et al. The metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems. 2011 Food Funct pmid:21779561
Kim J et al. Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. 2012 Free Radic. Biol. Med. pmid:22609359
Zhu LH et al. Puerarin attenuates high-glucose-and diabetes-induced vascular smooth muscle cell proliferation by blocking PKCbeta2/Rac1-dependent signaling. 2010 Free Radic. Biol. Med. pmid:19854265
Zou Y et al. Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3β/Nrf2 signaling pathway. 2013 Free Radic. Res. pmid:23088308
Branco DM et al. Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis. 2010 Front Aging Neurosci pmid:20577640
Chen YY et al. Puerarin protects human umbilical vein endothelial cells against high glucose-induced apoptosis by upregulating heme oxygenase-1 and inhibiting calpain activation. 2012 Fundam Clin Pharmacol pmid:21352351
Li R et al. Puerarin exerts the protective effect against chemical induced dysmetabolism in rats. 2016 Gene pmid:27677221
Xu X et al. Puerarin, isolated from Pueraria lobata (Willd.), protects against diabetic nephropathy by attenuating oxidative stress. 2016 Gene pmid:27317894
Fu R et al. Digital gene expression analysis of the pathogenesis and therapeutic mechanisms of ligustrazine and puerarin in rat atherosclerosis. 2014 Gene pmid:25218235
Jiang QD and Li XP Effect of puerarin on the expression of NMU, NPY, and POMC genes in the hypothalamus. 2016 Genet. Mol. Res. pmid:26985919
Plontke S Therapy of hearing disorders - conservative procedures. 2005 GMS Curr Top Otorhinolaryngol Head Neck Surg pmid:22073049
Chen B et al. [The rapid analysis of functional components of P. Lobata by near infrared spectrum]. 2002 Guang Pu Xue Yu Guang Pu Fen Xi pmid:12914179
Han MX et al. [Identification of three-step IR spectra of radix Puerariae from different habitats]. 2009 Guang Pu Xue Yu Guang Pu Fen Xi pmid:19798956
Zhang GW et al. [Studies on the interaction between puerarin and bovine serum albumin]. 2007 Guang Pu Xue Yu Guang Pu Fen Xi pmid:18051529
Zhang XP et al. Protective effects of Ligustrazine, Kakonein and Panax Notoginsenoside on the small intestine and immune organs of rats with severe acute pancreatitis. 2011 HBPD INT pmid:22146628
Liu H et al. Puerarin and zinc additively prevent mandibular bone loss through inhibiting osteoclastogenesis in ovariectomized rats. 2017 Histol. Histopathol. pmid:27966208
Jung DY et al. Induction of growth hormone release by Pueraria thunbergiana BENTH. 2004 Horm. Metab. Res. pmid:15002057
Liu G et al. Puerarin protects against lead-induced cytotoxicity in cultured primary rat proximal tubular cells. 2014 Hum Exp Toxicol pmid:24505050
Wang L et al. Protective effects of puerarin on experimental chronic lead nephrotoxicity in immature female rats. 2013 Hum Exp Toxicol pmid:23315276
Peng XY et al. [Study on the differentiation and apoptosis of HL-60 cell line induced by Puerarin]. 2001 Hunan Yi Ke Da Xue Xue Bao pmid:12536642
Ning Y et al. [Effects of purerarin on blood superoxide dismutase activities and plasma malondialdehyde levels in patients with angina pectoris]. 1997 Hunan Yi Ke Da Xue Xue Bao pmid:9868043
Duan S et al. [Effect of puerarin on heart function and serum oxidized-LDL in the patients with chronic cardiac failure]. 2000 Hunan Yi Ke Da Xue Xue Bao pmid:12212215
Wang J et al. Puerarin attenuates airway inflammation by regulation of eotaxin-3. 2015 Immunol. Lett. pmid:25530546
Semalty A et al. Development and evaluation of pharmacosomes of aceclofenac. 2010 Indian J Pharm Sci pmid:21694988
Wu M et al. Effects of delayed puerarin treatment in long-term neurological outcomes of focal ischemic stroke in rats. 2014 Mar-Apr Indian J Pharmacol pmid:24741185
Zhang J et al. Puerarin attenuates cognitive dysfunction and oxidative stress in vascular dementia rats induced by chronic ischemia. 2015 Int J Clin Exp Pathol pmid:26191159
Gasser P et al. Glycation induction and antiglycation activity of skin care ingredients on living human skin explants. 2011 Int J Cosmet Sci pmid:21401648
Wang K et al. Neuroprotective Effect of Puerarin on Glutamate-Induced Cytotoxicity in Differentiated Y-79 Cells via Inhibition of ROS Generation and Ca(2+) Influx. 2016 Int J Mol Sci pmid:27409614
Mazzio EA et al. The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease. 2011 Int J Mol Sci pmid:21340000
Hanhineva K et al. Impact of dietary polyphenols on carbohydrate metabolism. 2010 Int J Mol Sci pmid:20480025
Chen CC et al. Hazardous effects of curcumin on mouse embryonic development through a mitochondria-dependent apoptotic signaling pathway. 2010 Int J Mol Sci pmid:21152277
Li Q et al. Neuroprotective properties of picroside II in a rat model of focal cerebral ischemia. 2010 Int J Mol Sci pmid:21151457
Slámová K et al. "Sweet Flavonoids": Glycosidase-Catalyzed Modifications. 2018 Int J Mol Sci pmid:30037103
Lee IK et al. Compound K, a metabolite of ginseng saponin, induces mitochondria-dependent and caspase-dependent apoptosis via the generation of reactive oxygen species in human colon cancer cells. 2010 Int J Mol Sci pmid:21614182
Mukherjee B et al. Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers. 2008 Int J Nanomedicine pmid:19337417
Rudra A et al. Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats. 2010 Int J Nanomedicine pmid:21042545
Luo CF et al. Metabolic profile of puerarin in rats after intragastric administration of puerarin solid lipid nanoparticles. 2013 Int J Nanomedicine pmid:23486407
Wang J et al. Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies. 2017 Int J Nanomedicine pmid:29158673
Tang TT et al. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach. 2013 Int J Nanomedicine pmid:24277986
Kalani M and Yunus R Application of supercritical antisolvent method in drug encapsulation: a review. 2011 Int J Nanomedicine pmid:21796245